Uludağ, D. Et Al. 2022. Potential of Novel Methyl Jasmonate Analogs as Anticancer Agents to Metabolically Target HK-2 Activity in Glioblastoma Cells. Frontiers in Pharmacology , vol.13 .

Uludağ, D., Bay, S., SUCU, B. O., Şavluğ İpek, Ö., Mohr, T., GÜZEL, M., ... KARAKAŞ, N.(2022). Potential of Novel Methyl Jasmonate Analogs as Anticancer Agents to Metabolically Target HK-2 Activity in Glioblastoma Cells. Frontiers in Pharmacology , vol.13.

Uludağ, Damla Et Al. "Potential of Novel Methyl Jasmonate Analogs as Anticancer Agents to Metabolically Target HK-2 Activity in Glioblastoma Cells," Frontiers in Pharmacology , vol.13, 2022

Uludağ, Damla Et Al. "Potential of Novel Methyl Jasmonate Analogs as Anticancer Agents to Metabolically Target HK-2 Activity in Glioblastoma Cells." Frontiers in Pharmacology , vol.13, 2022

Uludağ, D. Et Al. (2022) . "Potential of Novel Methyl Jasmonate Analogs as Anticancer Agents to Metabolically Target HK-2 Activity in Glioblastoma Cells." Frontiers in Pharmacology , vol.13.

@article{article, author={Damla Uludağ Et Al. }, title={Potential of Novel Methyl Jasmonate Analogs as Anticancer Agents to Metabolically Target HK-2 Activity in Glioblastoma Cells}, journal={Frontiers in Pharmacology}, year=2022}